Global Enteral Feeding Formulas Market to Grow at a CAGR Value of 5.5% By 2028

The global enteral feeding formulas market size was worth USD 5,819.5 million in 2021 and is estimated to grow to USD 8,024.1 million by 2028, with a compound annual growth rate (CAGR) of roughly 5.5% over the forecast period. The report analyzes the enteral feeding formulas market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the enteral feeding formulas market.

The digestive system is made up of the mouth, the esophagus, the stomach, and the intestines. Food is ingested through the gastrointestinal tract during enteral feeding. It may also refer to food consumed through a tube inserted into the small intestine or stomach. This phrase is frequently used in the medical field as an alternative to tube feeding. It is administered to patients whose injuries prevent them from orally consuming a typical diet but whose GI tracts are still capable of working. The patient can absorb nutrients and maintain an active GI tract through tube feeding. It might serve as a supplement or the total caloric intake amount.

Among the key factors anticipated to propel the adoption of enteral feeding formulas and subsequently accelerate market growth over the forecast years are an increase in the incidence of chronic diseases and an increase in the aging population, both of which are at high risk of several life-threatening disorders, such as cardiovascular disease, diabetes, cancer, liver failure, and renal failure. The adoption of enteral feeding formulae to meet babies' nutritional needs is also fueled by the rise in the incidence of preterm births, which is projected to propel the global enteral feeling formulas market over time. One of the main factors influencing the introduction of enteral feeding formulae is an increase in the prevalence of malnutrition linked to greater ICU mortality. The market for enteral feeding formula is constrained by several concerns, including patient safety risks, enteral feeding difficulties, and the frequency of medication & feeding errors.

The global enteral feeding formulas market is segregated based on product, stage, application, end-user, and region. Based on product, the market is divided into standard formulas and disease-specific formulas. In 2021, standard formulas dominated with a share of 53.7%. Based on stage, the market is divided into adults and pediatrics. The adult category had the biggest revenue share of 88.6% in 2021. Based on application, the market is divided into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. In the market for enteral feeding formulas, the oncology segment had a significant market share in 2021. The market is divided into hospitals and long-term care facilities based on end-users. In 2021, the long-term care facilities had the largest revenue share of 56.3%.

In 2021, North America's revenue share was 28.9%, which was the highest regional share. Growth in the burden of chronic diseases like cancer, diabetes, and neurological problems is responsible for this income share. The market in this region is also anticipated to be driven by rising consumer awareness of the advantages of tube feeding for managing chronic health issues in the region. The popularity of enteral feeding formulas in North America is also fueled by a rise in the number of Americans suffering from gastrointestinal diseases. 

The rise in population, in patients with chronic diseases, and in the prevalence of malnutrition are expected to cause the Asia Pacific region to have the fastest growth during the projected period. Additionally, one of the primary drivers of regional development is the rise in preterm births in Asian nations. Furthermore, increasing healthcare spending in many Asian nations, including Japan, China, India, and Singapore, as well as increased awareness of better nutrition management, are anticipated to propel the market in the years to come.

Key players in the global enteral feeding formulas market include Abbott Laboratories, Nestlé S.A., Danone S.A., Mead Johnson Nutrition Company, Fresenius Kabi AG, Hormel Foods, LLC, Global Health Product Inc., B. Braun Melsungen AG, Meiji Holdings Co., Ltd., and Victus Inc.

Recent Development:

• In October 2020, Nestle Health Science introduced China's first protein-based total nutrition Foods under Special Medical Purposes (FSMPs) for malnourished people. The medication has been designed to treat the issue of inflammation and weakened immunity in patients, and it contains arginine, omega-3 fish oil, nucleotides, along with other crucial nutritional components.
• In June 2020, Otsuka Pharmaceutical Factory Inc. introduced new flavors of "ENORAS Liquid for Enteral Use," including coffee and strawberry (ethical pharmaceutical for a feeding tube and oral administration). Based on the most recent nutritional research, the product is a concentrated (1.6 kcal/mL) polymeric enteric nutrition solution that delivers nutrients and energy in small amounts.

Browse the full “Enteral Feeding Formulas Market By Product (Standard Formulas and Disease-Specific Formulas), By Stage (Adults and Pediatrics), By Application (Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, and Other Applications), By End-User (Hospitals and Long-term Care Facilities), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/enteral-feeding-formulas-market

Global Enteral Feeding Formulas Market is segmented as follows:

By Product

• Standard Formulas
• Disease-specific Formulas

By Stage

• Adults
• Pediatrics

By Application

• Oncology
• Gastroenterology
• Neurology
• Diabetes
• Critical Care
• Other Applications

By End User

• Hospitals
• Long-term Care Facilities

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com